Biomimetic nanoplatform with H<sub>2</sub>O<sub>2</sub> homeostasis disruption and oxidative stress amplification for enhanced chemodynamic therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36934891.
- Also identified by DOI 10.1016/j.actbio.2023.03.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemodynamic therapy (CDT) is a powerful cancer treatment strategy by producing excessive amount of reactive oxygen species (ROS) to kill cancer cells. However, the inadequate hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) supply and antioxidant defense systems in tumor tissue significantly impair the therapeutic effect of CDT, hindering its further applications. Herein, we present an intelligent nanoplatform with H<sub>2</sub>O<sub>2</sub> homeostasis disruption and oxidative stress amplification properties for enhanced CDT. This nanoplatform is obtained by encapsulating glucose oxidase (GOx) in a pH- and glutathione (GSH)-responsive degradable copper doped-zeolitic imidazolate framework (Cu-ZIF8), followed by loading of 3-amino-1,2,4-triazole (3AT) and modification of hyaluronic acid (HA) for tumor targeting delivery. The GOx@Cu-ZIF8-3AT@HA not only reduces energy supply and increases H<sub>2</sub>O<sub>2</sub> level by exhausting intratumoral glucose, but also disturbs tumor antioxidant defense systems by inhibiting the activity of catalase (CAT) and depleting intracellular GSH, resulting in disrupted H<sub>2</sub>O<sub>2</sub> homeostasis in tumor. Moreover, the elevated H<sub>2</sub>O<sub>2</sub> will transform into highly toxic hydroxyl radical (·OH) by Cu<sup>+</sup> that generated from redox reaction between Cu<sup>2+</sup> and GSH, amplifying the oxidative stress to enhance the CDT efficacy. Consequently, GOx@Cu-ZIF8-3AT@HA has significantly inhibited the 4T1 xenograft tumor growth without discernible side effects, which provides a promising strategy for cancer management. STATEMENT OF SIGNIFICANCE: The inadequate H<sub>2</sub>O<sub>2</sub> level and antioxidant defense system in tumor tissues significantly impair the therapeutic effect of CDT. Herein, we developed an intelligent nanoplatform with H<sub>2</sub>O<sub>2</sub> homeostasis disruption and oxidative stress amplification properties for enhanced CDT. In this nanoplatform, GOx could exhaust intratumoral glucose to reduce energy supply accompanied with production of H<sub>2</sub>O<sub>2</sub>, while the suppression of CAT activity by 3AT and depletion of GSH by Cu<sup>2+</sup> would weaken the antioxidant defense system of tumors. Ultimately, the raised H<sub>2</sub>O<sub>2</sub> level would convert to highly toxic •OH by Fenton-like reaction, amplifying the CDT efficacy. This work provides a promising strategy for cancer management.
Medical subject headings
- Antioxidants
- Neoplasms